Richard E Rupp (Richard Rupp)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Cervical Cancer Screening

Randomized Controlled Trial

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin L Russell, Richard E Rupp, Javier O Morales-Ramirez, Clemente Diaz-Perez, Charles P Andrews, Andrew W Lee, Tyler S Finn, Kara S Cox, Amy Falk Russell, Margaret M Schaller, Jason C Martin, Donna M Hyatt, Sabrina Gozlan-Kelner, Androniki Bili, Beth-Ann G Coller
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults. Human vaccines & immunotherapeutics 18 (5) (2022)
Jacqueline M Hirth, Kayla A Eboreime, Leslie E Cofie, Richard E Rupp, Abbey B Berenson
Human papillomavirus dose reminder preferences among parents from a diverse clinical sample: a qualitative study. Human vaccines & immunotherapeutics 18 (1) (2022)
Jacqueline M Hirth, Abbey B Berenson, Leslie E Cofie, Lena Matsushita, Yong-Fang Kuo, Richard E Rupp
Caregiver acceptance of a patient navigation program to increase human papillomavirus vaccination in pediatric clinics: a qualitative program evaluation. Human vaccines & immunotherapeutics 15 (7-8) (2019)
Abbey B Berenson, Jacqueline M Hirth, Erika L Fuchs, Mihyun Chang, Richard E Rupp
An educational intervention to improve attitudes regarding HPV vaccination and comfort with counseling among US medical students. Human vaccines & immunotherapeutics 16 (5) (2019)
Abbey B Berenson, Richard E Rupp, Erin E Dinehart, Leslie E Cofie, Yong-Fang Kuo, Jacqueline M Hirth
Achieving high HPV vaccine completion rates in a pediatric clinic population. Human vaccines & immunotherapeutics 15 (7-8) (2018)